The European Society of Medical Oncology (ESMO) Congress is held each year to bring together clinicians and researchers from all over the world, and at this year’s conference, new and emerging breast cancer treatments took center stage. Tune in as Dr. Matt Birnholz recaps those advances on the ESMO Congress floor in Barcelona, Spain.

Joining Dr. Matt Birnholz at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain to talk about his recent study titled, Agreement Between Patients and Oncologists on the Severity of the Patient’s Symptoms and Functions During a One-Year Follow-Up After Breast Cancer Treatment, is Dr. Randi Reidunsdatter.

At the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, Dr. Matt Birnholz got a chance to talk with Dr. Hans Petter Eikesdal about the head-turning study on PARP inhibitors he presented at the conference.

The curriculum will include highlights from the National Lipid Association symposium presented in a multi-part, structured activity that is engaging and interactive.

As the burden of various cardiac rhythm disorders increases, and their management becomes more evolved and sophisticated, clinicians need to understand how artificial intelligence technology is increasing the accuracy of wearable ECG monitoring systems. These systems can record the ECG and then send it to the Cloud where computations are performed, and a diagnosis is made with high accuracy that is transmitted to physicians so they can make a diagnosis and make decisions on managing patients with arrhythmias such as atrial fibrillation.

After the “Nutritional Therapy for IBD: From Theory to Your Practice” session at the second annual Crohn’s & Colitis Congress in Las Vegas, dietician Kelly Issokson and Dr. James Lewis recap the key takeaways, how you can implement those takeaways into your practice, and the benefits of recruiting dieticians and other healthcare professionals to provide your IBD patients with nutritional therapy.

Recorded at the second annual Crohn’s & Colitis Congress in Las Vegas, Dr. Athos Bousvaros and Dr. Andrew Grossman discuss IBD among pediatric patients and how optimizing various therapies is critically important to achieving disease remission.

To help ensure that you and your patients are on the same page, the Crohn’s & Colitis Foundation creates a Health Maintenance Checklist each year. Join Dr. Alan Moss as he breaks down this checklist at the second annual Crohn’s & Colitis Congress in Las Vegas.

The number of IBD patients who find themselves with colorectal cancer has decreased over the past ten years due to better screening tools and medication. And to help continue that trend, Dr. Animesh Jain and Dr. David Hudesman discuss the unique risk factors and the importance of early screening at the second annual Crohn’s & Colitis Congress in Las Vegas.

Dr. Maria Abreu and the Medical Director of Schubert-Martin Inflammatory Bowel Disease Center Dr. Michael Rosen discuss one of the sessions at the second annual Crohn’s & Colitis Congress, entitled “Environmental Triggers and Stemming the Rising Tide of IBD.”